Plant science companies Floragenex and BioDiagnostics have partnered to offer their sequencing-based SNP discovery and genotyping services to customers in the seed industry, the companies said last week.
Under the agreement, BDI customers will have access to Floragenex' DNA sequencing and molecular marker discovery services, while Floragenex customers can use testing and genotyping services offered by BDI.
Floragenex, based in Eugene, Ore., has developed a sequencing-based method that allows researchers to gain SNP information for species whose genomes have not yet been sequenced.
The method, called Restriction site Associated DNA, or RAD, LongRead sequencing, analyzes DNA around restriction enzyme sites and generates contigs up to 600 bases in length from Illumina Genome Analyzer sequence data. According to the company's website, this is enough flanking sequence to design effective assays on "any of the leading commercial genotyping platforms."
The two companies plan initially to collaborate on projects for customers in the agronomic and vegetable crop markets.